5-Iodo-2-methylbenzoic acid

We are 5-Iodo-2-methylbenzoic acid CAS:54811-38-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:5-Iodo-2-methylbenzoic acid
CAS.NO:54811-38-0
Synonyms:5-Iodo-2-methylbenzoic acid
5-Iodo-2-methylbenzoicacid
2-Methyl-5-Iodobenzoic acid
5-Iod-2-methyl-benzoesaeure
5-Jod-2-methylbenzoesaeure
 
Physical and Chemical Properties:
Density 1.9±0.1 g/cm3
Boiling Point 339.6±30.0 °C at 760 mmHg
Molecular Formula C8H7IO2
Molecular Weight 262.044
Flash Point 159.2±24.6 °C
Vapour Pressure 0.0±0.8 mmHg at 25°C
Index of Refraction 1.646
 
Specification:
Appearance:White crystalline powder
Assay:≥98.0%
Loss on drying:≤0.5%
Melting point:177-181°C
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Canagliflozin(CAS:842133-18-0).

5-Iodo-2-methylbenzoic acid


Related News: With the improvement of people’s living standards and the aging degree, the demand for medicines has been increasing for a long time. Therefore, the transfer from finished medicines to bulk medicines has greatly promoted the demand for bulk medicines.O-(Benzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium Hexafluorophosphate CAS:94790-37-1 “No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,” said Kristen Devito, Global Director, Catalent Clinical Supply Services.2-(Trifluoromethoxy)aniline CAS:1535-75-7 Featured APIs: Production capacity continues to expand, targeted patents expire. Original research drugs: industry entry barriers are high, performance stability and certainty are high.4- (trifluorometoxi) fenol CAS:828-27-3 The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.Process: The importance of safety is obvious. The research and development of specialty drug substances (especially high-barrier generic drug substance drugs) usually need to avoid the original process patents, and some chemicals are developed because of the complex structure or the harsh synthetic conditions The synthetic route is more difficult, so the importance of process design capabilities of API companies is becoming more important.

Related Products
Product Name
2-(Trifluoromethoxy)ethylamine, hydrochloride Cas:886050-51-7 View Details
3-Bromo-5-fluoro-2-methoxypyridine View Details
N,N-dimethyl-3-oxobutanamide View Details
Lanreotide Acetate manufacturer 1-Hydroxy-7-azabenzotriazole manufacturer 4-(2-bromoacetyl)benzonitrile manufacturer METHYL TRIFLUOROPYRUVATE Cas:13089-11-7 manufacturer 2-methyl-5-(trifluoromethyl)aniline manufacturer